BP / Pharma Projects Ltd. / Pharmacybrands Ltd / /
Country
Slovenia / Mexico / Macedonia / Kuwait / South Africa / New Zealand / Egypt / Thailand / Indonesia / Turkey / Malaysia / Bosnia and Herzegovina / United States / Brazil / Vietnam / Canada / Australia / Portugal / United Kingdom / Morocco / Jamaica / Argentina / Lebanon / South Korea / Greece / Palestinian Territories / /
Event
FDA Phase / /
Facility
American College of Obstetricians / University of California / /
University of California / Centre for Adverse Reactions Monitoring / World Health Organisation / Pharmaceutical Society of Australia / School of Public Health / Obstetricians and Gynecologists’ Committee / International Planned Parenthood Federation Medical Committee / the American College / FDA / /
Person
Daniel Grossman / Malcolm Potts / /
Position
general practitioner / pharmacist / physician / US obstetrician and gynaecologist / obstetrician and gynaecologist in the US / obstetrician /gynaecologist and public health physician / Selected Oral Contraceptives Executive / Chair / obstetrician and gynaecologist / /
Submission for Reclassification of Selected Oral Contraceptives Executive Summary Oral contraceptives are one of the most used, most studied, and most effective medicines in use today. Oral contraceptives provide protect